Free Trial

Nxera Pharma (SOLTF) Short Interest Ratio & Short Volume

$10.53
0.00 (0.00%)
(As of 07/26/2024 ET)

Nxera Pharma Short Interest Data

Current Short Interest
2,450,700 shares
Previous Short Interest
2,370,400 shares
Change Vs. Previous Month
+3.39%
Dollar Volume Sold Short
$25.09 million
Short Interest Ratio
24,507.0 Days to Cover
Last Record Date
July 15, 2024
Today's Trading Volume
0 shares
Average Trading Volume
1,803 shares
Today's Volume Vs. Average
0%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Nxera Pharma ?

Sign up to receive the latest short interest report for Nxera Pharma and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

SOLTF Short Interest Over Time

SOLTF Days to Cover Over Time

SOLTF Percentage of Float Shorted Over Time

Nxera Pharma Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/15/20242,450,700 shares $25.09 million +3.4%N/A24507 $10.24
6/30/20242,370,400 shares $22.35 million +0.2%N/A23704 $9.43
6/15/20242,365,000 shares $23.65 million +7.5%N/A11824.9 $10.00
5/31/20242,200,500 shares $19.52 million -9.1%N/A7335 $8.87
5/15/20242,419,800 shares $23.71 million -1.6%N/A12099 $9.80
4/30/20242,460,000 shares $22.89 million +13.1%N/A8200 $9.30
4/15/20242,175,400 shares $22.71 million +8.9%N/A7251.3 $10.44
3/31/20241,996,800 shares $21.02 million -7.4%N/A19968 $10.53
3/15/20242,156,300 shares $23.17 million -5.0%N/A287.5 $10.75
2/29/20242,269,300 shares $19.79 million +13.2%N/A22693 $8.72
2/15/20242,004,900 shares $17.34 million +22.3%N/A5012.3 $8.65
1/15/20241,294,200 shares $14.09 million -1.2%N/A2157 $10.89
12/31/20231,309,700 shares $13.10 million +8.2%N/A1437.6 $10.00
12/15/20231,211,000 shares $12.09 million -9.0%N/A2422 $9.98
11/30/20231,330,900 shares $13.24 million +25.3%N/A3327.3 $9.95
11/15/20231,062,100 shares $10.38 million -29.0%N/A5310.5 $9.77
10/31/20231,495,200 shares $13.35 million -6.8%N/A4984 $8.93
10/15/20231,603,600 shares $15.91 million -1.7%N/A1781.8 $9.92
9/30/20231,631,100 shares $16.64 million -6.0%N/A1812.3 $10.20
9/15/20231,735,300 shares $18.48 million -0.5%N/A2169.1 $10.65
8/31/20231,743,600 shares $20.26 million -0.8%N/A1748.9 $11.62
8/15/20231,757,400 shares $21.09 million -17.2%N/A5858 $12.00
7/31/20232,121,800 shares $27.48 million +52.4%N/A5304.5 $12.95
7/15/20231,392,500 shares $15.08 million +8.6%N/A633 $10.83
6/30/20231,281,900 shares $13.46 million -15.3%N/A145.7 $10.50
6/15/20231,513,300 shares $32.28 million -31.4%N/A1513.3 $21.33
5/31/20232,204,300 shares $49.37 million +6.7%N/A4408.6 $22.40
5/15/20232,065,500 shares $43.54 million +13.8%N/A10327.5 $21.08
4/30/20231,815,800 shares $35.92 million +19.7%N/A1513.2 $19.78
4/15/20231,516,400 shares $30.72 million +13.3%N/A3791 $20.26
3/31/20231,338,100 shares $22.68 million +3.1%N/A418.2 $16.95
3/15/20231,297,400 shares $23.56 million +19.7%N/A158.2 $18.16
2/28/20231,083,900 shares $17.61 million +1.3%N/A142.6 $16.25
2/15/20231,069,700 shares $16.63 million -5.1%N/A10697 $15.54
1/31/20231,127,500 shares $17.53 million +14.3%N/A0 $15.54
1/15/2023986,700 shares $15.34 million +27.9%N/A4933.5 $15.54
12/30/2022771,500 shares $11.99 million +1.2%N/A7715 $15.54
12/15/2022762,600 shares $8.66 million -14.9%N/A0 $11.36
11/30/2022896,200 shares $10.18 million -18.0%N/A0 $11.36
11/15/20221,093,100 shares $12.42 million -7.4%N/A0 $11.36
Get out of cash before the Fed's next meeting (Ad)

"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all $20,000 of his wife's 401k into shares of just ONE stock. Everyone on Wall Street said he was crazy. But a year later, that $20,000 in his wife's account was worth $120,000. Today, he says: "If you thought the dot-com mania was intense, what's about to happen in the coming weeks could be even crazier and could open up a new window of opportunity for 500%-plus gains."

Click here now to watch this exclusive interview
10/31/20221,180,100 shares $13.41 million -9.7%N/A0 $11.36
10/15/20221,306,300 shares $14.84 million -3.8%N/A0 $11.36
9/30/20221,357,200 shares $15.42 million +0.8%N/A0 $11.36
9/15/20221,346,500 shares $15.30 million -3.7%N/A0 $11.36
8/31/20221,397,800 shares $15.88 million +32.3%N/A6989 $11.36
8/15/20221,056,200 shares $13.04 million +5.9%N/A3520.7 $12.35
7/31/2022997,700 shares $8.42 million -2.6%N/A0 $8.44
7/15/20221,024,600 shares $8.65 million -24.0%N/A0 $8.44
6/30/20221,347,300 shares $11.37 million -1.9%N/A0 $8.44
6/15/20221,373,200 shares $11.59 million -7.6%N/A0 $8.44
5/31/20221,485,500 shares $12.54 million -1.9%N/A0 $8.44
5/15/20221,514,900 shares $12.79 million -0.5%N/A15149 $8.44
4/30/20221,521,700 shares $19.60 million -3.5%N/A0 $12.88
4/15/20221,577,200 shares $20.31 million +0.9%N/A0 $12.88
3/31/20221,563,500 shares $20.14 million +7.6%N/A0 $12.88
3/15/20221,453,100 shares $18.72 million -3.3%N/A14531 $12.88
2/28/20221,502,400 shares $19.19 million -23.8%N/A0 $12.77
2/15/20221,970,800 shares $25.17 million -10.2%N/A0 $12.77
1/31/20222,193,500 shares $28.01 million -12.0%N/A10967.5 $12.77
1/15/20222,491,300 shares $42.53 million +9.2%N/A0 $17.07
12/31/20212,280,600 shares $38.93 million +6.2%N/A22806 $17.07
12/15/20212,148,000 shares $40.00 million +2.3%N/A0 $18.62
11/30/20212,100,300 shares $44.13 million +35.8%N/A21003 $21.01
11/15/20211,546,400 shares $23.86 million +1.5%N/A7732 $15.43
10/29/20211,523,900 shares $26.94 million -0.3%N/A0 $17.68
10/15/20211,529,100 shares $27.03 million +12.6%N/A0 $17.68
9/30/20211,358,400 shares $24.65 million -7.5%N/A13584 $18.15
9/15/20211,467,700 shares $23.97 million +0.5%N/A0 $16.33
8/31/20211,459,800 shares $23.84 million +3.2%N/A0 $16.33
8/13/20211,414,500 shares $23.10 million -2.0%N/A0 $16.33
7/30/20211,443,400 shares $23.57 million -0.1%N/A0 $16.33
7/15/20211,444,200 shares $23.58 million +22.3%N/A7221 $16.33
6/30/20211,180,500 shares $19.28 million +8.7%N/A11805 $16.33
6/15/20211,085,800 shares $14.40 million +13.5%N/A0 $13.26
5/28/2021956,600 shares $12.68 million +1.4%N/A1594.3 $13.26
5/14/2021943,100 shares $15.61 million +2.2%N/A0 $16.55
4/30/2021922,600 shares $15.27 million -0.3%N/A0 $16.55
4/15/2021925,400 shares $15.32 million -11.0%N/A0 $16.55
3/31/20211,039,500 shares $17.20 million -10.2%N/A0 $16.55
3/15/20211,157,500 shares $19.16 million -22.9%N/A11575 $16.55
2/26/20211,500,700 shares $24.45 million -17.1%N/A0 $16.29
2/12/20211,810,000 shares $29.48 million -7.4%N/A0 $16.29
1/29/20211,954,800 shares $31.84 million +9.6%N/A0 $16.29
1/15/20211,605,500 shares $26.15 million -6.0%N/A16055 $16.29
12/31/20201,712,600 shares $27.04 million +6.7%N/A0 $15.79
12/15/20201,605,500 shares $25.35 million -6.0%N/A16055 $15.79
11/30/20201,708,300 shares $25.45 million +17.1%N/A0 $14.90
11/15/20201,458,900 shares $20.05 million -6.4%N/A14589 $13.74
10/30/20201,557,900 shares $17.39 million +12.0%N/A7789.5 $11.16
10/15/20201,391,000 shares $17.62 million +3.0%N/A0 $12.67
Get out of cash before the Fed's next meeting (Ad)

"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all $20,000 of his wife's 401k into shares of just ONE stock. Everyone on Wall Street said he was crazy. But a year later, that $20,000 in his wife's account was worth $120,000. Today, he says: "If you thought the dot-com mania was intense, what's about to happen in the coming weeks could be even crazier and could open up a new window of opportunity for 500%-plus gains."

Click here now to watch this exclusive interview
9/30/20201,351,200 shares $17.12 million +5.0%N/A6756 $12.67
9/15/20201,287,400 shares $17.23 million +7.0%N/A1839.1 $13.38
8/31/20201,202,800 shares $16.48 million +18.8%N/A0 $13.70
8/14/20201,012,700 shares $13.87 million -4.2%N/A10127 $13.70
7/31/20201,056,500 shares $15.27 million +0.7%N/A1760.8 $14.45
7/15/20201,048,800 shares $16.79 million +48.3%N/A0 $16.01
6/30/2020707,400 shares $11.33 million -1.9%N/A3537 $16.01
6/15/2020721,100 shares $10.43 million +2.4%N/A7211 $14.47
5/29/2020704,500 shares $8.45 million +1.3%N/A0 $12.00
5/15/2020695,600 shares $8.35 million -12.4%N/A0 $12.00
4/30/2020794,400 shares $9.53 million -5.3%N/A0 $12.00
4/15/2020838,700 shares $10.06 million -12.1%N/A8387 $12.00
3/31/2020953,600 shares $11.44 million -11.9%N/A0 $12.00
3/13/20201,082,400 shares $12.99 million -1.4%N/A10824 $12.00
2/28/20201,097,900 shares $14.33 million +3.3%N/A0 $13.05
2/14/20201,062,500 shares $13.87 million +2.6%N/A0 $13.05
1/31/20201,035,200 shares $17.92 million -4.5%N/A0 $17.31
1/15/20201,084,000 shares $20.30 million -10.3%N/A10840 $18.73
12/31/20191,208,100 shares $22.63 million +14.2%N/A12081 $18.73

SOLTF Short Interest - Frequently Asked Questions

What is Nxera Pharma's current short interest?

Short interest is the volume of Nxera Pharma shares that have been sold short but have not yet been closed out or covered. As of July 15th, investors have sold 2,450,700 shares of SOLTF short. Learn More on Nxera Pharma's current short interest.

What is a good short interest ratio for Nxera Pharma?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SOLTF shares currently have a short interest ratio of 24,507.0. Learn More on Nxera Pharma's short interest ratio.

Is Nxera Pharma's short interest increasing or decreasing?

Nxera Pharma saw a increase in short interest during the month of July. As of July 15th, there was short interest totaling 2,450,700 shares, an increase of 3.4% from the previous total of 2,370,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks.

What does it mean to sell short Nxera Pharma stock?

Short selling SOLTF is an investing strategy that aims to generate trading profit from Nxera Pharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Nxera Pharma?

A short squeeze for Nxera Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SOLTF, which in turn drives the price of the stock up even further.

How often is Nxera Pharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SOLTF, twice per month. The most recent reporting period available is July, 15 2024.



This page (OTCMKTS:SOLTF) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners